SCHEMBL6173958

SCHEMBL6173958

CC1(Cc2ccnc3cccc(Cl)c23)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
AR P10275 5/20 0.35
IGF1R P08069 1/20 0.35
POLB P06746 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ITGAL P20701 1/20 0.34
LIPE Q05469 2/20 0.34
TEAD1 P28347 2/20 0.34
TEAD4 Q15561 2/20 0.34
TEAD2 Q15562 2/20 0.34
TEAD3 Q99594 2/20 0.34
HSD17B13 Q7Z5P4 2/20 0.34
HTT P42858 1/20 0.34
PIK3CG P48736 1/20 0.34
PIK3CD O00329 1/20 0.33
TRPV4 Q9HBA0 1/20 0.33
NTRK1 P04629 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6171026 0.86 AR (0.35) ARIGF1RPOLBL3MBTL1ITGAL
SCHEMBL6174017 0.86 IGF1R (0.43) ARIGF1R
SCHEMBL6173567 0.85 IGF1R (0.51) ARIGF1RITGALHTT
SCHEMBL6173695 0.81 ITGAL (0.40) ARPOLBL3MBTL1ITGALLIPE
SCHEMBL2938890 0.80 IGF1R (0.54) IGF1RNTRK1
SCHEMBL6172285 0.79 MAPK7 (0.39) ARIGF1RPOLBL3MBTL1TEAD1
SCHEMBL6174950 0.79 POLB (0.35) ARIGF1RPOLBL3MBTL1TEAD1
SCHEMBL6171211 0.79 HCRTR1 (0.39) POLBL3MBTL1
SCHEMBL6177887 0.79 PIK3CG (0.37) ARPOLBL3MBTL1LIPEHSD17B13
SCHEMBL6175888 0.77 GRM5 (0.35) ARIGF1RPOLBL3MBTL1TEAD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed